source
- Nascent US psychedelic therapy opportunity attracts overseas manufacturersCompanies that manufacture MDMA and psilocybin for patients in other countries are looking to use their experience to access the potential U.S. market.BioSpace · 21m ago↗ source
- FDA grants accelerated approval to Bristol Myers' iberdomide for relapsed or refractory multiple myelomaThe U.S. Food and Drug Administration has issued an accelerated approval for iberdomide, a small-molecule therapy developed by Bristol Myers Squibb. The approval targets patients with multiple mye…